Anand Anbarasu

Employment

• VIT University Professor
  2003 - 2014
• Christian Medical College Vellore Research Officer
  2000 - 2001
• Vignan University Lecturer
  1999 - 2000
• Christian Medical College Vellore Research Officer
  1998 - 1999

Education

• VIT University PhD
  2004 - 2007
• Sathyabama University M.Tech.,
  2001 - 2003
• Christian Medical College Vellore M.Sc.,
  1995 - 1998
• University of Madras B.Sc.,
  1992 - 1995

Projects & Funding

Projects & funding information is unavailable.

Publications (135)

• Waning immunity and the future of booster vaccination strategies in global vaccine programs post COVID-19
  Human Vaccines & Immunotherapeutics 2026 DOI: 10.1080/21645515.2026.2626088
  +Save
• Microbial bacteriocins as natural biopreservatives: monitoring strategies for a sustainable food system
  Applied Food Research 2026 DOI: 10.1016/j.afres.2026.102524
  +Save
• In Silico Analysis of an Antidiabetic Drug Canagliflozin as a Potential Inhibitor of Penicillin‐Binding Protein 3 in Acinetobacter baumannii
  ChemistrySelect 2026 DOI: 10.1002/slct.74219
  +Save
• Marmin-Derivatives as Promising Inhibitors of Cysteine Synthases from Mycobacterium Tuberculosis: An in silico Approach
  Journal of Computational Biophysics and Chemistry 2026 DOI: 10.1142/S2737416525500929
  +Save
• In silico genomic analysis of resistome, virulome, and mobilome of β-lactamase-producing Klebsiella pneumoniae
  Scientific Reports 2026 DOI: 10.1038/s41598-026-56520-7
  +Save
• Machine Learning-Enabled Network Biology Analysis for Biomarker Discovery: Uncovering Molecular Interactions between Endocrine-Disrupting Chemicals and Hormone-Sensitive Cancers
  Journal of Computational Biophysics and Chemistry 2026 DOI: 10.1142/S2737416525500760
  +Save
• Data-Driven Discovery of a Key Regulator Cyclin A2 as a Promising Therapeutic Target in Hormone-Sensitive Cancers
  Molecular Biotechnology 2026 DOI: 10.1007/s12033-025-01504-7
  +Save
• A comprehensive review of resistome profiles in ocular pathogens: Insights into Pseudomonas aeruginosa and emerging resistance trends
  Journal of Infection and Public Health 2026 DOI: 10.1016/j.jiph.2026.103183
  +Save
• Pharmacokinetics Screening, Molecular Docking, and Dynamics Simulations Revealed Novel Antimicrobial Peptide NKLF2 Mutants as Potent Inhibitors of Mycobacterium tuberculosis
  Probiotics and Antimicrobial Proteins 2026 DOI: 10.1007/s12602-025-10608-0
  +Save
• Screening of natural compounds potentially inhibiting the mutated C-terminal domain of GyrA in Salmonella Typhi using ML-based in silico approach
  Network Modeling Analysis in Health Informatics and Bioinformatics 2025 DOI: 10.1007/s13721-025-00632-z
  +Save